Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Postoperative continuous intravenous nefopam for analgesia after decompressive lumbar laminectomy and fusion
TCTR20220615006Phase 4Unknown
- Sponsor
- N/A
- Start
- Jul 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of nefopam in degenerative lumbar spinal stenosis (LSS), postoperative pain, sponsored by N/A. Status: unknown.
02
Drugs
nefopam
03
Conditions
degenerative lumbar spinal stenosis (LSS)postoperative pain
Beyond the preview
Go deeper on TCTR20220615006.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20220615006.